Home DailyMed 19c7e562-b887-43ee-8f2a-801a408c4877 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 01:14:48
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020449-001 TAXOTERE DOCETAXEL 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 N020449-003 TAXOTERE DOCETAXEL 20MG/ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-03 N020449-004 TAXOTERE DOCETAXEL 80MG/4ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-02 N020449-005 TAXOTERE DOCETAXEL 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020449-005 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020449-003 TAXOTERE 20MG/ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-03 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-02 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020449-003 TAXOTERE 20MG/ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13 c2088c7a36db…2026-09-14 22:38:34 2026-08 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020449-003 TAXOTERE 20MG/ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020449-003 TAXOTERE 20MG/ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 2010-08-02 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020449-003 TAXOTERE 20MG/ML (20MG/ML) INJECTABLE / INJECTION RLD 2010-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) INJECTABLE / INJECTION RLD 2010-08-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020449-003 TAXOTERE 20MG/ML (20MG/ML) INJECTABLE / INJECTION RLD 2010-08-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) INJECTABLE / INJECTION RLD 2010-08-02 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020449-003 TAXOTERE 20MG/ML (20MG/ML) INJECTABLE / INJECTION RLD 2010-08-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) INJECTABLE / INJECTION RLD 2010-08-02 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD 2012-04-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020449-003 TAXOTERE 20MG/ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2010-08-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2010-08-02 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2012-04-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020449-003 TAXOTERE 20MG/ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2010-08-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2010-08-02 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2012-04-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020449-001 TAXOTERE 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE / INJECTION RLD 1996-05-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020449-003 TAXOTERE 20MG/ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2010-08-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020449-004 TAXOTERE 80MG/4ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2010-08-02 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020449-005 TAXOTERE 160MG/8ML (20MG/ML) INJECTABLE / INJECTION AP RLD, RS 2012-04-13 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 119 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.